Put BlueChew GOLD in its own comparison column. It describes sildenafil, tadalafil, apomorphine and oxytocin in a sublingual product, rather than every treatment sold by BlueChew. A useful comparison keeps the medicine, the supply and the payment interval together. Otherwise a cheaper-looking figure may describe a different formula or a larger commitment.
Availability: Public product listing; individual eligibility and current prescription require confirmation.
The exact product
The first comparison field is the actual preparation. The material distinction here is the rationale and evidence for four active ingredients. Match every active ingredient and dosage form before looking at timing or unit cost. Products with similar names can contain different drugs; products with the same drug can use different formulations. Neither resemblance establishes interchangeability. The identity table is a record of the provider's listing, not a prescription-selection tool.
| Provider | BlueChew |
|---|---|
| Listed active ingredients | Sildenafil + tadalafil + apomorphine + oxytocin |
| Dosage form | Compounded sublingual tablet |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | BlueChew: platform, care process, and safety information · BlueChew: GOLD product and plan information · BlueChew: GOLD published cost breakdown |
Price, supply and payment
The quoted public price is Public price examples differ; confirm the selected offer. Treat the details below as the boundaries of that quote. Only calculate a unit figure when both the charge and the supplied quantity belong to the same offer; only calculate a monthly equivalent when the payment term is known. A blank quantity or renewal price should remain blank. Comparing invented complete totals is less reliable than explaining why two published offers cannot yet be matched.
| GOLD-specific article | Approx. $18.28 each / 6 tablets; $11.65 each / 18 quarterly |
|---|---|
| Different cost article | Approx. $75 for 6 monthly doses |
| Price conclusion | Conflicting public examples; no universal confirmed quote |
| Oxytocin study boundary | 29 healthy couples, intranasal route; not the GOLD combination |
What the research can support
Evidence is another comparison field, not a bonus point for a more complicated formula. This product's relevant evidence includes single-ingredient apomorphine trials and intranasal oxytocin research, not a GOLD trial. The missing comparison concerns comparative benefit of the finished four-drug preparation. A valid superiority claim would need a suitable comparator and outcome, not merely different marketing language. Record whether the source measured erection outcomes, subjective preference, absorption or something else before treating a percentage or timing claim as comparable.
| Evidence boundary | single-ingredient apomorphine trials and intranasal oxytocin research, not a GOLD trial |
|---|---|
| Not established here | comparative benefit of the finished four-drug preparation |
| Clinical and regulatory references | FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · FDA: Locate a state-licensed online pharmacy · Behnia et al. (2014): intranasal oxytocin in couples · Dula et al. (2001): sublingual apomorphine crossover trial · MedlinePlus: Sildenafil · MedlinePlus: Tadalafil |
Safety questions for the prescriber
Cost matching does not establish clinical suitability. A clinician must review nitrates, recreational nitrites, riociguat, other ED drugs, blood-pressure treatment and relevant medical history before prescribing. Do not try to recreate BlueChew GOLD with cheaper separate medicines. A do-it-yourself combination can create a new exposure without reproducing the studied or prescribed preparation. The specific safety distinction below can change which comparisons are meaningful for an individual.
| Multiple PDE5 inhibitors | Standard tadalafil labeling advises against combining PDE5 inhibitors; individualized rationale and monitoring are needed. |
|---|---|
| Apomorphine | A separate active ingredient; a single-ingredient trial is not a trial of this combination. |
Availability and the actual prescription
There is little value in ranking a price for an offer you cannot select. Our access finding is: Public product listing; individual eligibility and current prescription require confirmation. Account restrictions and a medical eligibility decision are different filters. Obtain confirmation of the exact current product before comparing cancellation rules or moving away from an existing plan. A product page that remains reachable is evidence of public documentation, not a guarantee of inventory or enrollment.
Refills, changes and cancellation
Add a change-of-treatment row to the budget. Ask whether a new formula requires another assessment, a replacement supply or a separate charge, and whether the current order can still be stopped. For the clinical side, use “What evidence supports the added ingredients for my specific concern?” The two answers should come from the appropriate teams. A support agent's billing explanation does not settle medication safety, and a clinical message does not necessarily stop automatic processing.
| Hold choices | A one-order skip differs from an indefinite stop-until-return setting. |
|---|---|
| Cancellation notice | At least 24 hours before renewal in the published policy. |
| Clinical plan changes | Account FAQ requests 48 hours; changes do not affect an order already processing. |
| Returns | Prescription returns are not accepted. |
| Policy sources | BlueChew: account and subscription questions · BlueChew: returns and refunds policy |
Compare named products
The alternatives below are selected because they share an ingredient, format or clinical question. They are not ranked by efficacy. Compare them using the same columns: complete ingredients, supplied form, prescribed schedule, quantity, amount due and renewal. If one column remains unknown, identify that limitation in the comparison rather than awarding the offer a value advantage based on a starting banner.
Questions to keep with the offer
The decision-ready comparison is a written quote plus a prescribing explanation. The public records for BlueChew GOLD can narrow the questions but cannot provide those personal answers. No test purchase, clinical trial or pharmacy inspection was performed for this review. Sources identify advertised facts and evidence limits; commercial presentation elsewhere on this publication is not a clinical score.
| Ask about this formula | What evidence supports the added ingredients for my specific concern? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
Check the source
Public pages checked October 7, 2026. Provider material establishes advertised terms, not independently verified clinical results.
- BlueChew: platform, care process, and safety informationProvider source; current featured product and service description
- BlueChew: GOLD product and plan informationProvider source; four-ingredient compounded formulation
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- FDA: Locate a state-licensed online pharmacyGovernment pharmacy verification resource
- BlueChew: GOLD published cost breakdownProvider marketing article; approximate price examples, not a checkout quote
- BlueChew: account and subscription questionsProvider policy; plan changes, one-order skips, and indefinite holds
- BlueChew: shipping and delivery questionsProvider policy; destination availability, shipping, and renewal terms
- BlueChew: returns and refunds policyProvider policy; prescription returns and 24-hour cancellation notice
- Behnia et al. (2014): intranasal oxytocin in couplesPrimary study; 29 healthy couples, different route and population from GOLD, abstract reviewed via NCBI
- Dula et al. (2001): sublingual apomorphine crossover trialPrimary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI
- BlueChew: product-specific approximate costsProvider price examples; approximate and not necessarily consistent with other offer pages
- MedlinePlus: SildenafilDrug information; standard sildenafil products
- MedlinePlus: TadalafilDrug information; standard tadalafil products